A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Medically reviewed by Femi Aremu, PharmD Skin rashes can have many different causes, one of which is medications. The ...

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...

Earlier this week, it was announced that King Charles III was forced to cancel public events after suffering side effects of ...

To advance this research towards commercialization, Daniel Fologea benefits from an NSF Transform grant for marketed oriented ...